Showing results (131-140 of 1,597) with videos related to
Sort By:
Pageof 160
Annual Review of Genomics and Human Genetics|May 6, 2016
Phenome-Wide Association Studies as a Tool to Advance Precision MedicineJoshua C Denny, Lisa Bastarache, Dan M RodenJournal of Clinical Pharmacology|July 1, 1984
Antiarrhythmic therapy: clinical pharmacology updateR L Woosley, I Cerskus, D M RodenHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 1, 1993
Increase in skeletal muscle blood flow but not in renal blood flow during euglycemic hyperinsulinemia in manH Vierhapper, S Gasic, M Roden, et al.Circulation Research|May 1, 1999
Calmodulin kinase inhibition prevents development of the arrhythmogenic transient inward currentY Wu, D M Roden, M E AndersonAnnals of Biomedical Engineering|February 24, 2001
Delayed activation and retrograde propagation in cardiac muscle: implication of virtual electrode effectsJ Wu, D M Roden, J P WikswoCirculation|March 15, 1995
Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effectsT Yang, D J Snyders, D M RodenMetabolism: Clinical and Experimental|March 1, 1992
Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liverM Roden, H Vierhapper, K Liener, et al.The Pharmacogenomics Journal|February 11, 2009
Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERGB F McBride, T Yang, D M RodenThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Inhibition of cardiac potassium currents by the vesnarinone analog OPC-18790: comparison with quinidine and dofetilideT Yang, D J Snyders, D M RodenDeutsche Medizinische Wochenschrift (1946)|July 4, 2013
[Rare cause of recurrent hypoglycaemia in type 1 diabetes mellitus--case 6/2013]F Schwarz, M Roden, A Fritsche, et al.Pageof 160